Serveur d'exploration sur l'oranger

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.

Identifieur interne : 000934 ( PubMed/Curation ); précédent : 000933; suivant : 000935

Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.

Auteurs : Julius Oben [Cameroun] ; Ebangha Enonchong ; Shil Kothari ; Walter Chambliss ; Robert Garrison ; Deanne Dolnick

Source :

RBID : pubmed:19682376

English descriptors

Abstract

The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on joint health in overweight and normal weight adults diagnosed with osteoarthritis.

DOI: 10.1186/1475-2891-8-38
PubMed: 19682376

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:19682376

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.</title>
<author>
<name sortKey="Oben, Julius" sort="Oben, Julius" uniqKey="Oben J" first="Julius" last="Oben">Julius Oben</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Nutrition & Nutritional Biochemistry, Department of Biochemistry, University of Yaounde I, Cameroon. juliusoben@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Cameroun</country>
<wicri:regionArea>Laboratory of Nutrition & Nutritional Biochemistry, Department of Biochemistry, University of Yaounde I</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Enonchong, Ebangha" sort="Enonchong, Ebangha" uniqKey="Enonchong E" first="Ebangha" last="Enonchong">Ebangha Enonchong</name>
</author>
<author>
<name sortKey="Kothari, Shil" sort="Kothari, Shil" uniqKey="Kothari S" first="Shil" last="Kothari">Shil Kothari</name>
</author>
<author>
<name sortKey="Chambliss, Walter" sort="Chambliss, Walter" uniqKey="Chambliss W" first="Walter" last="Chambliss">Walter Chambliss</name>
</author>
<author>
<name sortKey="Garrison, Robert" sort="Garrison, Robert" uniqKey="Garrison R" first="Robert" last="Garrison">Robert Garrison</name>
</author>
<author>
<name sortKey="Dolnick, Deanne" sort="Dolnick, Deanne" uniqKey="Dolnick D" first="Deanne" last="Dolnick">Deanne Dolnick</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19682376</idno>
<idno type="pmid">19682376</idno>
<idno type="doi">10.1186/1475-2891-8-38</idno>
<idno type="wicri:Area/PubMed/Corpus">000934</idno>
<idno type="wicri:Area/PubMed/Curation">000934</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.</title>
<author>
<name sortKey="Oben, Julius" sort="Oben, Julius" uniqKey="Oben J" first="Julius" last="Oben">Julius Oben</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Nutrition & Nutritional Biochemistry, Department of Biochemistry, University of Yaounde I, Cameroon. juliusoben@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Cameroun</country>
<wicri:regionArea>Laboratory of Nutrition & Nutritional Biochemistry, Department of Biochemistry, University of Yaounde I</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Enonchong, Ebangha" sort="Enonchong, Ebangha" uniqKey="Enonchong E" first="Ebangha" last="Enonchong">Ebangha Enonchong</name>
</author>
<author>
<name sortKey="Kothari, Shil" sort="Kothari, Shil" uniqKey="Kothari S" first="Shil" last="Kothari">Shil Kothari</name>
</author>
<author>
<name sortKey="Chambliss, Walter" sort="Chambliss, Walter" uniqKey="Chambliss W" first="Walter" last="Chambliss">Walter Chambliss</name>
</author>
<author>
<name sortKey="Garrison, Robert" sort="Garrison, Robert" uniqKey="Garrison R" first="Robert" last="Garrison">Robert Garrison</name>
</author>
<author>
<name sortKey="Dolnick, Deanne" sort="Dolnick, Deanne" uniqKey="Dolnick D" first="Deanne" last="Dolnick">Deanne Dolnick</name>
</author>
</analytic>
<series>
<title level="j">Nutrition journal</title>
<idno type="eISSN">1475-2891</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>C-Reactive Protein (metabolism)</term>
<term>Citrus (chemistry)</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Joints (drug effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Osteoarthritis (drug therapy)</term>
<term>Overweight (drug therapy)</term>
<term>Phellodendron (chemistry)</term>
<term>Pilot Projects</term>
<term>Plant Extracts (administration & dosage)</term>
<term>Plant Extracts (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>C-Reactive Protein</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Citrus</term>
<term>Phellodendron</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Joints</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Osteoarthritis</term>
<term>Overweight</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on joint health in overweight and normal weight adults diagnosed with osteoarthritis.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">19682376</PMID>
<DateCreated>
<Year>2009</Year>
<Month>9</Month>
<Day>9</Day>
</DateCreated>
<DateCompleted>
<Year>2009</Year>
<Month>12</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>12</Month>
<Day>7</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1475-2891</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<PubDate>
<Year>2009</Year>
<Month>Aug</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Nutrition journal</Title>
<ISOAbbreviation>Nutr J</ISOAbbreviation>
</Journal>
<ArticleTitle>Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.</ArticleTitle>
<Pagination>
<MedlinePgn>38</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1475-2891-8-38</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on joint health in overweight and normal weight adults diagnosed with osteoarthritis.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">An 8-week placebo-controlled, randomized, double-blind study was conducted with four groups comparing the effects of NP 06-1 to placebo on overweight and normal weight subjects diagnosed with primary osteoarthritis of the knee. NP 06-1 (a combination of two botanical extracts; Phellodendron amurense bark and Citrus sinensis peel) or matching placebo were given in a dose of two capsules (370 mg each) twice daily. The outcome measures were the Lequesne Algofunctional Index (LAI) for joint pain and movement as well as biomarkers of inflammation (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty (80) subjects were enrolled and 45 subjects completed the study. No serious adverse events were reported. The mean total LAI scores at baseline for the four groups ranged from 11.4 to 12.4 (SD 1.2 to 2.4). Treatment for 8 weeks resulted in a statistical improvement in the LAI score in the overweight treatment group compared to placebo (6.3 +/- 2.3 vs 11.8 +/- 1.5; p < 0.0001). At 8 weeks, a similar result was observed in the normal weight groups (7.7 +/- 1.4 vs 9.9 +/- 0.9; p < 0.0001). There was a reduction in CRP levels with treatment in the overweight treatment group at 8 weeks (-0.62 +/- 0.2; 49%) compared to baseline (p < 0.001) and to placebo (p < 0.001). For the normal weight participants, there were significant reductions in CRP compared to baseline, but not to the matched placebo group. Both overweight and normal weight treatment groups lost a significant amount of weight compared to their placebo groups. The overweight treatment group lost an average of 5% body weight after 8 weeks. There was no significant change in ESR in any of the groups.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this pilot study, NP 06-1 had beneficial effects on symptoms of osteoarthritis of the knee as measured using LAI scores and had anti-inflammatory effects as measured using CRP. Administration of NP 06-1 was also associated with weight loss, which may have been a contributing factor to the other benefits.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oben</LastName>
<ForeName>Julius</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Nutrition & Nutritional Biochemistry, Department of Biochemistry, University of Yaounde I, Cameroon. juliusoben@hotmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Enonchong</LastName>
<ForeName>Ebangha</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kothari</LastName>
<ForeName>Shil</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chambliss</LastName>
<ForeName>Walter</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Garrison</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dolnick</LastName>
<ForeName>Deanne</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>ENG</Language>
<PublicationTypeList>
<PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>Aug</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nutr J</MedlineTA>
<NlmUniqueID>101152213</NlmUniqueID>
<ISSNLinking>1475-2891</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C545281">NP 06-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Immunopharmacol Immunotoxicol. 1999 Nov;21(4):771-86</RefSource>
<PMID Version="1">10584211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocr Rev. 2008 Dec;29(7):777-822</RefSource>
<PMID Version="1">18971485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Life Sci. 2003 Aug 1;73(11):1401-12</RefSource>
<PMID Version="1">12850501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2004 Jan 20;203(2):127-37</RefSource>
<PMID Version="1">14732220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lipids. 2004 Feb;39(2):143-51</RefSource>
<PMID Version="1">15134141</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Agric Food Chem. 2004 May 19;52(10):2879-86</RefSource>
<PMID Version="1">15137829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheum. 1986 Aug;29(8):1039-49</RefSource>
<PMID Version="1">3741515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Pharm Bull. 1994 Feb;17(2):262-5</RefSource>
<PMID Version="1">7515744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Immunopharmacol. 1996 Oct;18(10):553-61</RefSource>
<PMID Version="1">9080249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Rheumatol. 1997 Apr;24(4):779-81</RefSource>
<PMID Version="1">9101517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Rheumatol. 1997 Aug;24(8):1486-8</RefSource>
<PMID Version="1">9263139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nat Prod. 1999 Mar;62(3):441-4</RefSource>
<PMID Version="1">10096854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Atherosclerosis. 2005 Jan;178(1):25-32</RefSource>
<PMID Version="1">15585197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Life Sci. 2006 Jun 20;79(4):365-73</RefSource>
<PMID Version="1">16497336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2006 Aug;55(8):2256-64</RefSource>
<PMID Version="1">16873688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Mol Med. 2006 Dec 31;38(6):599-605</RefSource>
<PMID Version="1">17202835</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2007 Jan 8;167(1):31-9</RefSource>
<PMID Version="1">17210875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Res Ther. 2006;8(4):R127</RefSource>
<PMID Version="1">16859534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Best Pract Res Clin Rheumatol. 2007 Feb;21(1):59-76</RefSource>
<PMID Version="1">17350544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Rheum Dis. 2007 Apr;66(4):433-9</RefSource>
<PMID Version="1">17204567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2007 May;15(5):516-23</RefSource>
<PMID Version="1">17157039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2007 Aug;15(8):966-71</RefSource>
<PMID Version="1">17395501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nutr J. 2008;7:16</RefSource>
<PMID Version="1">18492265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rheumatology (Oxford). 2001 Jul;40(7):779-93</RefSource>
<PMID Version="1">11477283</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002957" MajorTopicYN="N">Citrus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007596" MajorTopicYN="N">Joints</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D032102" MajorTopicYN="N">Phellodendron</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2739863</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2009</Year>
<Month>6</Month>
<Day>4</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2009</Year>
<Month>8</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2009</Year>
<Month>8</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2009</Year>
<Month>8</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2009</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19682376</ArticleId>
<ArticleId IdType="pii">1475-2891-8-38</ArticleId>
<ArticleId IdType="doi">10.1186/1475-2891-8-38</ArticleId>
<ArticleId IdType="pmc">PMC2739863</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000934 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000934 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Bois
   |area=    OrangerV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:19682376
   |texte=   Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:19682376" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a OrangerV1 

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 17:11:04 2016. Site generation: Wed Mar 6 18:18:32 2024